These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9764806)

  • 1. Sensitivity of human melanoma cells to oestrogens, tamoxifen and quercetin: is there any relationship with type I and II oestrogen binding site expression?
    Lama G; Angelucci C; Bruzzese N; Iacopino F; Nori SL; D'Atri S; Turriziani M; Bonmassar E; Sica G
    Melanoma Res; 1998 Aug; 8(4):313-22. PubMed ID: 9764806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites.
    Scambia G; Ranelletti FO; Benedetti Panici P; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Pierelli L; Capelli A; Mancuso S
    Cancer Chemother Pharmacol; 1991; 28(4):255-8. PubMed ID: 1879042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.
    Caltagirone S; Ranelletti FO; Rinelli A; Maggiano N; Colasante A; Musiani P; Aiello FB; Piantelli M
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):51-9. PubMed ID: 9224209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids.
    Scambia G; Ranelletti FO; Benedetti Panici P; Piantelli M; Rumi C; Battaglia F; Larocca LM; Capelli A; Mancuso S
    Int J Cancer; 1990 Dec; 46(6):1112-6. PubMed ID: 2249899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT; Duwe G
    Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids.
    Larocca LM; Piantelli M; Leone G; Sica S; Teofili L; Panici PB; Scambia G; Mancuso S; Capelli A; Ranelletti FO
    Br J Haematol; 1990 Aug; 75(4):489-95. PubMed ID: 2207000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells.
    Piantelli M; Maggiano N; Ricci R; Larocca LM; Capelli A; Scambia G; Isola G; Natali PG; Ranelletti FO
    J Invest Dermatol; 1995 Aug; 105(2):248-53. PubMed ID: 7636308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectin.
    Dewhurst LO; Gee JW; Rennie IG; MacNeil S
    Br J Cancer; 1997; 75(6):860-8. PubMed ID: 9062408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive association between cytoskeletal changes, melanoma cell attachment and invasion in vitro.
    Dewhurst LO; Rennie IG; MacNeil S
    Melanoma Res; 1998 Aug; 8(4):303-11. PubMed ID: 9764805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function.
    Miodini P; Fioravanti L; Di Fronzo G; Cappelletti V
    Br J Cancer; 1999 Jun; 80(8):1150-5. PubMed ID: 10376965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.
    Caltagirone S; Rossi C; Poggi A; Ranelletti FO; Natali PG; Brunetti M; Aiello FB; Piantelli M
    Int J Cancer; 2000 Aug; 87(4):595-600. PubMed ID: 10918203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system.
    Nakayama Y; Sakamoto H; Satoh K; Yamamoto T
    Cancer Lett; 2000 Dec; 161(1):63-71. PubMed ID: 11078914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model.
    Langdon SP; Crew AJ; Ritchie AA; Muir M; Wakeling A; Smyth JF; Miller WR
    Eur J Cancer; 1994; 30A(5):682-6. PubMed ID: 8080688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells.
    Scambia G; Ranelletti FO; Panici PB; Piantelli M; Bonanno G; De Vincenzo R; Ferrandina G; Rumi C; Larocca LM; Mancuso S
    Br J Cancer; 1990 Dec; 62(6):942-6. PubMed ID: 2257224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of laminin-binding integrins by 1 alpha,25-dihydroxyvitamin D3 in human melanoma cells in vitro.
    Hansen CM; Madsen MW; Arensbak B; Skak-Nielsen T; Latini S; Binderup L
    Cell Adhes Commun; 1998 Mar; 5(2):109-20. PubMed ID: 9638332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines.
    Scambia G; Ranelletti FO; Panici PB; Piantelli M; De Vincenzo R; Ferrandina G; Bonanno G; Capelli A; Mancuso S
    Int J Cancer; 1993 May; 54(3):462-6. PubMed ID: 8509221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.